Decanoic acid
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Decanoic acid
UNSPSC Description:
Decanoic acid is a key component of the medium-chain triglyceride (MCT) found in coconut oil. Decanoic acid is a brain-penetrant and non-competitive inhibitor of AMPA receptor showing antiseizure activity in rats. Decanoic acid reduces tyrosinase activity and inhibits melanosome maturation. Decanoic acid suppresses the phosphorylation of c-Met and induced apoptosis in hepatocellular carcinoma (HCC) cells by inhibiting the expression of various oncogenic proteins, which is promising for research in the field of mTORC1 signaling, HCC and epilepsy[1][2][3].Target Antigen:
c-Met/HGFR; Endogenous Metabolite; Glutaminase; iGluR; TyrosinaseType:
Natural ProductsRelated Pathways:
Membrane Transporter/Ion Channel;Metabolic Enzyme/Protease;Neuronal Signaling;Protein Tyrosine Kinase/RTKApplications:
Metabolism-sugar/lipid metabolismField of Research:
Cancer; Metabolic Disease; Neurological DiseaseAssay Protocol:
https://www.medchemexpress.com/Decanoic_acid.htmlPurity:
98.0Solubility:
DMSO : ≥ 130 mg/mLSmiles:
CCCCCCCCCC(O)=OMolecular Weight:
172.27References & Citations:
[1]Boison D, et, al. New insights into the mechanisms of the ketogenic diet. Curr Opin Neurol. 2017 Apr;30(2):187-192.|[2]Chang P, et al. Seizure control by decanoic acid through direct AMPA receptor inhibition. Brain. 2016 Feb;139(Pt 2):431-43.|[3]Kim S, et, al. Selective production of decanoic acid from iterative reversal of β-oxidation pathway. Biotechnol Bioeng. 2018 May;115(5):1311-1320.|[4]Warren EC, et al. Decanoic acid inhibits mTORC1 activity independent of glucose and insulin signaling[J]. Proc Natl Acad Sci U S A. 2020 Sep 22;117(38):23617-23625.|[5]Yang MH, et al. Decanoic Acid Exerts Its Anti-Tumor Effects via Targeting c-Met Signaling Cascades in Hepatocellular Carcinoma Model[J]. Cancers (Basel). 2023 Sep 22;15(19):4681.Shipping Conditions:
Room TemperatureStorage Conditions:
Store at room temperature 3 yearsClinical Information:
No Development ReportedCAS Number:
334-48-5
